735 related articles for article (PubMed ID: 17960872)
1. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
[TBL] [Abstract][Full Text] [Related]
2. Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications.
Yellepeddi VK; Kumar A; Palakurthi S
Expert Opin Drug Deliv; 2009 Aug; 6(8):835-50. PubMed ID: 19637972
[TBL] [Abstract][Full Text] [Related]
3. Studies on polyamidoamine dendrimers as efficient gene delivery vector.
Hui Zhong ; He ZG; Zheng Li ; Li GY; Shen SR; Li XL
J Biomater Appl; 2008 May; 22(6):527-44. PubMed ID: 17623709
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
[TBL] [Abstract][Full Text] [Related]
5. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.
Zhang XQ; Intra J; Salem AK
Bioconjug Chem; 2007; 18(6):2068-76. PubMed ID: 17848077
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Bioconjug Chem; 2007; 18(3):937-46. PubMed ID: 17355118
[TBL] [Abstract][Full Text] [Related]
7. Solubility of nicotinic acid in polyamidoamine dendrimer solutions.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Dec; 40(12):1384-9. PubMed ID: 16226352
[TBL] [Abstract][Full Text] [Related]
8. Transepithelial and endothelial transport of poly (amidoamine) dendrimers.
Kitchens KM; El-Sayed ME; Ghandehari H
Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433
[TBL] [Abstract][Full Text] [Related]
9. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization.
Saovapakhiran A; D'Emanuele A; Attwood D; Penny J
Bioconjug Chem; 2009 Apr; 20(4):693-701. PubMed ID: 19271737
[TBL] [Abstract][Full Text] [Related]
10. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery.
Patil ML; Zhang M; Betigeri S; Taratula O; He H; Minko T
Bioconjug Chem; 2008 Jul; 19(7):1396-403. PubMed ID: 18576676
[TBL] [Abstract][Full Text] [Related]
11. Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers.
Pisal DS; Yellepeddi VK; Kumar A; Palakurthi S
Drug Deliv; 2008 Nov; 15(8):515-22. PubMed ID: 18720134
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of the effect of poly(amidoamine) dendrimers on the porosity of epithelial monolayers.
Lin YL; Khanafer K; El-Sayed ME
Nanoscale; 2010 May; 2(5):755-62. PubMed ID: 20648321
[TBL] [Abstract][Full Text] [Related]
13. Guanidino- and urea-modified dendrimers as potent solubilizers of misfolded prion protein aggregates under non-cytotoxic conditions. dependence on dendrimer generation and surface charge.
Cordes H; Boas U; Olsen P; Heegaard PM
Biomacromolecules; 2007 Nov; 8(11):3578-83. PubMed ID: 17918894
[TBL] [Abstract][Full Text] [Related]
14. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen.
Yiyun C; Tongwen X; Rongqiang F
Eur J Med Chem; 2005 Dec; 40(12):1390-3. PubMed ID: 16226353
[TBL] [Abstract][Full Text] [Related]
15. Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin.
Kono K; Kojima C; Hayashi N; Nishisaka E; Kiura K; Watarai S; Harada A
Biomaterials; 2008 Apr; 29(11):1664-75. PubMed ID: 18194811
[TBL] [Abstract][Full Text] [Related]
16. Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.
Pisal DS; Yellepeddi VK; Kumar A; Kaushik RS; Hildreth MB; Guan X; Palakurthi S
Int J Pharm; 2008 Feb; 350(1-2):113-21. PubMed ID: 17913410
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.
Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L
Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123
[TBL] [Abstract][Full Text] [Related]
18. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
Patri AK; Kukowska-Latallo JF; Baker JR
Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
[TBL] [Abstract][Full Text] [Related]
19. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
Zhang XQ; Wang XL; Huang SW; Zhuo RX; Liu ZL; Mao HQ; Leong KW
Biomacromolecules; 2005; 6(1):341-50. PubMed ID: 15638538
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins.
Devarakonda B; Hill RA; Liebenberg W; Brits M; de Villiers MM
Int J Pharm; 2005 Nov; 304(1-2):193-209. PubMed ID: 16198076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]